Journal for ImmunoTherapy of Cancer (Nov 2023)
1452 NCG-X is a triple immunodeficient mouse capable of being immune humanized without irradiation for use in immunotherapy preclinical research
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)